Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Quick fluid bolus or slow drip? study tests best way to calm Baby's heartbeat in labor

NCT ID NCT07260240

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study looks at 60 pregnant women in labor whose babies show a slightly concerning heart rate pattern (Category II). Doctors want to see if giving a fast fluid bolus works better than a slow continuous drip to improve the heart rate within 30 minutes. The goal is to find a simple, safe way to help both mom and baby during delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Dec 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton pregnancy * Thai nationality * Gestational age of 37 weeks or more * Maternal age from 20 to 35 years * Cephalic presentation * Category II electronic fetal monitoring tracing during labor Exclusion Criteria: * Pre-existing cardiac, pulmonary, thyroid, or overt diabetic disease * Pre-eclampsia or gestational diabetes * Suspected fetal structural anomaly, growth restriction, arrhythmia, or chromosomal abnormality * Recent magnesium sulfate or opioid analgesia * Oligohydramnios

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Category II fetal heart rate tracing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Queen Savang Vadhana Memorial Hospital

    Si Racha, Changwat Chon Buri, 20110, Thailand